Schroder Investment Management Group’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-437
| Closed | -$316K | – | 1322 |
|
|
2018
Q2 | $316K | Sell |
437
-501
| -53% | -$362K | ﹤0.01% | 1114 |
|
|
2018
Q1 | $1.5M | Buy |
938
+4
| +0.4% | +$6.38K | ﹤0.01% | 892 |
|
|
2017
Q4 | $837K | Buy |
934
+445
| +91% | +$399K | ﹤0.01% | 1013 |
|
|
2017
Q3 | $174K | Hold |
489
| – | – | ﹤0.01% | 1210 |
|
|
2017
Q2 | $142K | Hold |
489
| – | – | ﹤0.01% | 1183 |
|
|
2017
Q1 | $171K | Hold |
489
| – | – | ﹤0.01% | 1123 |
|
|
2016
Q4 | $90K | Hold |
489
| – | – | ﹤0.01% | 1067 |
|
|
2016
Q3 | $126K | Hold |
489
| – | – | ﹤0.01% | 1056 |
|
|
2016
Q2 | $104K | Hold |
489
| – | – | ﹤0.01% | 1066 |
|
|
2016
Q1 | $100K | Hold |
489
| – | – | ﹤0.01% | 1055 |
|
|
2015
Q4 | $124K | Hold |
489
| – | – | ﹤0.01% | 1060 |
|
|
2015
Q3 | $80K | Hold |
489
| – | – | ﹤0.01% | 1069 |
|
|
2015
Q2 | $91K | Hold |
489
| – | – | ﹤0.01% | 1084 |
|
|
2015
Q1 | $81K | Hold |
489
| – | – | ﹤0.01% | 1123 |
|
|
2014
Q4 | $114K | Sell |
489
-1,163
| -70% | -$271K | ﹤0.01% | 1156 |
|
|
2014
Q3 | $299K | Buy |
1,652
+1,163
| +238% | +$211K | ﹤0.01% | 1140 |
|
|
2014
Q2 | $94.1K | Hold |
489
| – | – | ﹤0.01% | 1197 |
|
|
2014
Q1 | $89K | Hold |
489
| – | – | ﹤0.01% | 1235 |
|
|
2013
Q4 | $83.3K | Hold |
489
| – | – | ﹤0.01% | 1309 |
|
|
2013
Q3 | $76.7K | Buy |
+489
| New | +$76.7K | ﹤0.01% | 1310 |
|